FL 33612 to permit rapid consideration for publication. ## Mutations in the Factor XI Gene To the Editor: Mutations in the factor XI gene are responsible for a variable bleeding phenotype which correlates poorly with levels of circulating FXI product. We read with interest and concern an article
A survey of the effectiveness of cyclophosphamide in patients with severe aplastic anemia
β Scribed by Dr. Paul F. Griner
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 402 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The development of alloantibodies to platelets is a major problem in the supportive management of thrombocytopenia in patients with severe aplastic anemia. We report here a case of aplastic anemia refractory to platelet transfusion. An immunosuppressant, cyclosporin A, which was used for the therapy
Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.